InvestorsHub Logo
Followers 229
Posts 14581
Boards Moderated 1
Alias Born 03/29/2014

Re: lunatick post# 18115

Sunday, 08/31/2014 12:07:59 PM

Sunday, August 31, 2014 12:07:59 PM

Post# of 688914
Take a look at the full article tab on this link of lunatick's. Under Tumor Cell-based Vaccines, authors reference clinical trial 5968 (L) but do not ref name of vaccine. Typing with one finger here so can't grab section. Then author references rindopepimut (celldex) by name twice in article.

Says the 68 trial has a "low accrual rate, illustrating the complexity of this approach" while the celldex trial has an "excellent accrual".
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News